Titan Biotech Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Net profit of Titan Biotech rose 1.01% to Rs 5.00 crore in the quarter ended March 2024 as against Rs 4.95 crore during the previous quarter ended March 2023. Sales rose 8.36% to Rs 39.92 crore in the quarter ended March 2024 as against Rs 36.84 crore during the previous quarter ended March 2023.

For the full year,net profit rose 0.04% to Rs 24.85 crore in the year ended March 2024 as against Rs 24.84 crore during the previous year ended March 2023. Sales rose 13.94% to Rs 164.07 crore in the year ended March 2024 as against Rs 144.00 crore during the previous year ended March 2023.

Powered by Capital Market - Live News

Titan Biotech announced that the Board of Directors of the Company at its meeting held on 29 May 2024, has recommended a Final dividend of Rs.2 per share (i.e.20%), subject to the approval of the shareholders.

Powered by Capital Market - Live News

Titan Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2024

Powered by Capital Market - Live News

Net profit of Titan Biotech rose 173.33% to Rs 7.38 crore in the quarter ended December 2023 as against Rs 2.70 crore during the previous quarter ended December 2022. Sales rose 51.60% to Rs 45.98 crore in the quarter ended December 2023 as against Rs 30.33 crore during the previous quarter ended December 2022.

Powered by Capital Market - Live News